title: Targeted therapies in rare sarcomas: IMT, ASPS, SFT, PEComa, and CCS.
abstract: This article highlights the data currently available on the activity of targeted medical treatment in a subgroup of rare entities within soft tissue sarcomas, including inflammatory myofibroblastic tumor, alveolar soft part sarcoma, solitary fibrous tumor, malignant perivascular epithelioid cell tumor (PEComa), and clear cell sarcoma.
authors.affiliation: Adult Sarcoma Medical Oncology Unit, Department of Cancer Medicine, Fondazione IRCCS Istituto Nazionale Tumori, via Venezian 1, Milan 20133, Italy. Electronic address: silvia.stacchiotti@istitutotumori.mi.it.
authors.forename: Silvia
authors.initials: S
authors.lastname: Stacchiotti
authors.forename: Andrea
authors.initials: A
authors.lastname: Marrari
authors.forename: Angelo P
authors.initials: AP
authors.lastname: Dei Tos
authors.forename: Paolo G
authors.initials: PG
authors.lastname: Casali
mesh_terms: D006801:Humans; D058990:Molecular Targeted Therapy; D012509:Sarcoma / Q000175:diagnosis* / Q000188:drug therapy*
keywords: Alveolar soft part sarcoma; Chemotherapy; Clear cell sarcoma; Hemangiopericytoma; Inflammatory myofibroblastic tumor; Perivascular epithelioid cell tumor; Sarcoma; Solitary fibrous tumor